(Q46691558)

English

Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

0 references

1 reference

based on heuristic

inferred from title

obsessive-compulsive disorder

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

7

0 references

author name string

Werner Zitterl

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

Martin Aigner

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

Thomas Stompe

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

Karin Zitterl-Eglseer

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

Karin Gutierrez-Lobos

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

Thomas Wenzel

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

Georg Zettinig

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

0000-0002-1258-4344

Walter Pirker

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

Kenneth Thau

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

language of work or name

0 references

publication date

19 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

33

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

13

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

3126-3134

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

https://scigraph.springernature.com/pub.10.1038/npp.2008.35

0 references

High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

The Yale-Brown Obsessive Compulsive Scale. II. Validity

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Reduced central serotonin transporters in alcoholism

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Serotonergic Function in Obsessive-Compulsive Disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

The epidemiology and cross-national presentation of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Toward a neuroanatomy of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Initial experience with single-photon emission tomography using iodine-123-labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane in human brain.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

[123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Obsessive-compulsive disorder in the community: an epidemiologic survey with clinical reappraisal

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD).

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

[123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

Enhanced Dopamine Transporter Density in Psychotropic-Naive Patients With Obsessive-Compulsive Disorder Shown by [ 123 I]β-CIT SPECT

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

[123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

21 January 2018

[3H]GBR 12935 binding to dopamine uptake sites in the human brain

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

7 January 2021

based on heuristic

inferred from DOI database lookup

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative electroencephalographic subtyping of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacotherapy of obsessive-compulsive disorder: experience with the selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.35

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NPP.2008.35

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18354388

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46691558&oldid=2126872950"